April 11th 2018
Alene Nitzky PhD, RN, OCN, incorporates creativity, authenticity, resourcefulness, and empathy into her career as a wellness consultant to survivors.
April 10th 2018
One versatile nurse used creative ways to ensure that displaced patients received their treatments on time.
April 9th 2018
The call bell light in room 12-204 was the first to go off at the crack of dawn, breaking the serene silence of the floor. “I need to shower so I can see the race!” the patient exclaimed.
April 6th 2018
"You treat a disease, you win, you lose. You treat a person, I guarantee you, you'll win, no matter what the outcome." - Robin Williams as Dr. Patch Adams
February 13th 2018
A nurse uses her creativity to gain the trust of a patient who was skeptical of an MIBG scan.
The Latest on Acute Lymphocytic Leukemia
View More
A Focus on Acute Myeloid Leukemia
View More
Updates in Myelodysplastic Syndromes
View More
Patient, Provider, and Caregiver Connection: Addressing Pediatric and AYA Patient Concerns While Managing Hodgkin Lymphoma
View More
Multidisciplinary Management of TNBC: Immunotherapy, PARP, TROP2, Oh My!
View More
Community Practice Connections™: The Advent of TROP2-Targeted Treatment Approaches in HR+/HER2- Breast Cancer
View More
8th Annual School of Nursing Oncology™
August 10, 2024
Register Now!
Applying New Evidence in Multiple Myeloma Care from Frontline to R/R Disease
View More
Medical Crossfire®: How Do Clinicians Integrate the Latest Evidence in Treating Ovarian Cancer to Personalize Care?
View More
Medical Crossfire®: How Does Recent Evidence on PARP Inhibitors and Combinations Inform Treatment Planning for Prostate Cancer Now and In the Future?
View More
Medical Crossfire®: Where Are We in the World of ADCs? From HER2 to CEACAM5, TROP2, HER3, CDH6, B7H3, c-MET and Beyond!
View More
Medical Crossfire: How Has Iron Supplementation Altered Treatment Planning for Patients with Cancer-Related Anemia?
View More
The Evolving Tool Box in Advanced HR+/HER2– Breast Cancer: What You Need to Know About Next-Generation SERDs, PI3K/AKT, ADCs, CDK4/6 and Beyond…
View More
Community Practice Connections™: 5th Annual Precision Medicine Symposium – An Illustrated Tumor Board
View More
Empowering Patients Along Their Cancer Journey
August 20th 2014Many studies are currently assessing the role of patient navigation in achieving both quantitative and qualitative improvements in cancer care, and metrics have been developed to capture demonstrable evidence for this relatively new subspecialty of oncology nursing practice. Yet amidst all this fact-finding lives an individual patient with cancer.
Cilta-cel Produces MRD Negativity, Responses in Relapsed/Refractory Multiple Myeloma
4 Strategies to Reduce Oncology Nurse Burnout, Stop ‘Silent Quitting’
Relapsed/Refractory Follicular Lymphoma May Respond to Loncastuximab Tesirine Plus Rituximab
Cilta-cel Demonstrates 99.4% ORR in Lenalidomide-Refractory Myeloma
2 Commerce Drive
Cranbury, NJ 08512